6.89
price up icon0.88%   0.06
after-market Handel nachbörslich: 6.84 -0.05 -0.73%
loading
Schlusskurs vom Vortag:
$6.83
Offen:
$6.76
24-Stunden-Volumen:
2.00M
Relative Volume:
0.99
Marktkapitalisierung:
$326.71M
Einnahmen:
$193.06M
Nettoeinkommen (Verlust:
$-22.51M
KGV:
-10.77
EPS:
-0.64
Netto-Cashflow:
$10.63M
1W Leistung:
+5.51%
1M Leistung:
-38.81%
6M Leistung:
-5.23%
1J Leistung:
+25.05%
1-Tages-Spanne:
Value
$6.60
$6.89
1-Wochen-Bereich:
Value
$6.4423
$7.163
52-Wochen-Spanne:
Value
$3.99
$15.84

Lifemd Inc Stock (LFMD) Company Profile

Name
Firmenname
Lifemd Inc
Name
Telefon
(866) 351-5907
Name
Adresse
236 FIFTH AVENUE, NEW YORK
Name
Mitarbeiter
336
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-10
Name
Neueste SEC-Einreichungen
Name
LFMD's Discussions on Twitter

Vergleichen Sie LFMD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Health Information Services icon
LFMD
Lifemd Inc
6.89 323.86M 193.06M -22.51M 10.63M -0.64
Health Information Services icon
VEEV
Veeva Systems Inc
279.18 45.01B 2.86B 780.66M 1.20B 4.72
Health Information Services icon
TEM
Tempus Ai Inc
69.63 11.53B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
64.02 11.58B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
89.27 8.04B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
35.35 6.03B 906.14M -52.62M 89.62M -0.3621

Lifemd Inc Stock (LFMD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-18 Bestätigt BTIG Research Buy
2024-12-10 Eingeleitet Lake Street Buy
2024-12-04 Eingeleitet Mizuho Neutral
2024-08-23 Fortgesetzt B. Riley Securities Buy
2024-06-05 Eingeleitet KeyBanc Capital Markets Overweight
2023-11-30 Eingeleitet Craig Hallum Buy
2023-07-21 Eingeleitet Cantor Fitzgerald Overweight
2023-07-03 Eingeleitet H.C. Wainwright Buy
2022-03-10 Eingeleitet Colliers Securities Buy
2021-10-04 Fortgesetzt B. Riley Securities Buy
Alle ansehen

Lifemd Inc Aktie (LFMD) Neueste Nachrichten

pulisher
11:21 AM

Rosen Law Firm Encourages LifeMD, Inc. Investors to Inquire About Securities Class Action Investigation – LFMD - Business Wire

11:21 AM
pulisher
Aug 12, 2025

Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare

Aug 12, 2025
pulisher
Aug 11, 2025

Dynex Capital, Inc. Declares Monthly Common Stock Dividend of $0.17 Per Common Share for August 2025 - The Globe and Mail

Aug 11, 2025
pulisher
Aug 10, 2025

Is LifeMD Inc. a top pick in the sectorBuyback Announcements Stock Watch - thegnnews.com

Aug 10, 2025
pulisher
Aug 08, 2025

HC Wainwright Lowers LifeMD Price Target to $13.00, Maintains "Buy" Rating - AInvest

Aug 08, 2025
pulisher
Aug 07, 2025

LifeMD price target lowered to $13 from $14 at H.C. Wainwright - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

LifeMD, Inc. (NASDAQ:LFMD) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 07, 2025
pulisher
Aug 07, 2025

Positive Sentiment Still Eludes LifeMD, Inc. (NASDAQ:LFMD) Following 46% Share Price Slump - simplywall.st

Aug 07, 2025
pulisher
Aug 07, 2025

LifeMD Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

Aug 07, 2025
pulisher
Aug 07, 2025

LifeMD (LFMD) Target Price Lowered by HC Wainwright & Co. to $13 - GuruFocus

Aug 07, 2025
pulisher
Aug 07, 2025

LifeMD’s Strong Growth Potential and Strategic Diversification Support Buy Rating Despite Revenue Guidance Adjustment - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

LifeMD: HC Wainwright lowers Buy rating to $13 from $14. - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Tidewater Inc.’s Financial Stability at Risk: How Debt Covenants Threaten Liquidity and Growth - The Globe and Mail

Aug 07, 2025
pulisher
Aug 06, 2025

LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates - MSN

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD Expects Q3 Adjusted EBITDA of $6M-$7M, Revenue Growth at 19.5%, and Mixed Financial Health - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD Reports Q2 2025 Revenue Growth of 23% to $62.2mln, Adjusted EBITDA Surges 223% to $7.1mln. - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD Stock Plummets 40%. Why Weight Loss Isn't Just A Gimme. - Investor's Business Daily

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD shares drop 44.55% intraday despite Q2 revenue growth and debt repayment. - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD stock price target lowered to $12 at KeyBanc on elevated costs - Investing.com Nigeria

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD price target lowered to $14 from $18 at Lake Street - TipRanks

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD Misses Estimates, But Keeps Growing And Diversifying - Finimize

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD Down Nearly 46%, on Track for Record Percent Decrease -- Data Talk - 富途牛牛

Aug 06, 2025
pulisher
Aug 06, 2025

Lake Street Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $14 - 富途牛牛

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD Plummets 44%: A Telehealth Titan's Turbulent Turnaround? - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD (LFMD) Analyst Lowers Price Target but Maintains Overweig - GuruFocus

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD Plummets 40.96%: Earnings Shock and Sector Headwinds Spark Investor Exodus - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD slumps after firm cuts 2025 revenue forecast - TradingView

Aug 06, 2025
pulisher
Aug 06, 2025

TR | OpenAI4o Maintains LifeMD(LFMD.US) With Hold Rating, Cuts Target Price to $12.5 - 富途牛牛

Aug 06, 2025
pulisher
Aug 06, 2025

KeyBanc Adjusts LifeMD (LFMD) Price Target Amid Business Strateg - GuruFocus

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD 2025 Q2 Earnings Significant Loss Reduction - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD (LFMD) Q2 Revenue Rises 23% - The Globe and Mail

Aug 06, 2025
pulisher
Aug 06, 2025

LifeMD, Inc. Reports Strong Q2 2025 Growth - TipRanks

Aug 06, 2025
pulisher
Aug 05, 2025

LifeMD’s CEO Makes a Bold Move with Significant Stock Sale - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD's Q2 2025 Earnings Call: Navigating Contradictions in Insurance Strategy and Customer Acquisition Costs - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD (LFMD) Revenues and Earnings Miss Expectations - GuruFocus

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD (LFMD) Updates Financial Guidance Amid Revenue Growth - GuruFocus

Aug 05, 2025
pulisher
Aug 05, 2025

Earnings call transcript: LifeMD Q2 2025 misses expectations, stock dips - Investing.com

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD CEO Schreiber sells $249,690 in shares By Investing.com - Investing.com Nigeria

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD CEO Schreiber sells $249,690 in shares - Investing.com

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD August 2025 slides: Virtual healthcare platform targets $255M in 2025 revenue - Investing.com Canada

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD August 2025 slides: Virtual healthcare platform targets $255M in 2025 revenue By Investing.com - Investing.com South Africa

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD reports Q2 EPS (6c) vs. (19c) last year - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD shares plunge as Q2 results miss, guidance cut By Investing.com - Investing.com Canada

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD shares plunge as Q2 results miss, guidance cut - Investing.com

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD cuts FY25 revenue view to $250M-$255M from $268M-$275M - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD Q2 revenue rises but misses expectations - MarketScreener

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada

Aug 05, 2025
pulisher
Aug 05, 2025

LifeMD Reports Second Quarter 2025 Results - GlobeNewswire

Aug 05, 2025
pulisher
Aug 04, 2025

LifeMD Inc (LFMD) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Aug 04, 2025
pulisher
Aug 04, 2025

LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire

Aug 04, 2025

Finanzdaten der Lifemd Inc-Aktie (LFMD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$33.24
price up icon 11.17%
$21.02
price up icon 1.50%
$22.39
price up icon 3.08%
$58.05
price up icon 3.68%
$3.24
price up icon 6.58%
health_information_services WAY
$35.35
price up icon 2.23%
Kapitalisierung:     |  Volumen (24h):